| Routine analyses of trace elements in geological samples using flow injection and low pressure on‐line liquid chromatography coupled to ICP‐MS: A study of geochemical reference … J Carignan, P Hild, G Mevelle, J Morel, D Yeghicheyan Geostandards Newsletter 25 (2‐3), 187-198, 2001 | 600 | 2001 |
| Treatment of primary Sjögren syndrome with rituximab: a randomized trial V Devauchelle-Pensec, X Mariette, S Jousse-Joulin, JM Berthelot, ... Annals of internal medicine 160 (4), 233-242, 2014 | 470 | 2014 |
| Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial JE Gottenberg, P Ravaud, X Puéchal, V Le Guern, J Sibilia, V Goeb, ... Jama 312 (3), 249-258, 2014 | 360 | 2014 |
| Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry D Salmon-Céron, F Tubach, O Lortholary, O Chosidow, S Bretagne, ... Annals of the rheumatic diseases 70 (4), 616-623, 2011 | 354 | 2011 |
| Effect of methotrexate, anti–tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a … C Hua, T Barnetche, B Combe, J Morel Arthritis care & research 66 (7), 1016-1026, 2014 | 330 | 2014 |
| Evidence of IL-18 as a novel angiogenic mediator CC Park, J Morel, MA Amin, MA Connors, LA Harlow, AE Koch The Journal of Immunology 167 (3), 1644-1653, 2001 | 323 | 2001 |
| Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant‐induced arthritis JH Ruth, MV Volin, GK Haines III, DC Woodruff, KJ Katschke Jr, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 301 | 2001 |
| Bone mineral density of 704 amateur sportsmen involved in different physical activities J Morel, B Combe, J Francisco, J Bernard Osteoporosis International 12, 152-157, 2001 | 278 | 2001 |
| Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases CI Daïen, A Monnier, P Claudepierre, A Constantin, JP Eschard, ... Rheumatology 48 (8), 883-886, 2009 | 275 | 2009 |
| Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease C Gabay, B Fautrel, J Rech, F Spertini, E Feist, I Kötter, E Hachulla, ... Annals of the rheumatic diseases 77 (6), 840-847, 2018 | 262 | 2018 |
| COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study J Avouac, E Drumez, E Hachulla, R Seror, S Georgin-Lavialle, ... The Lancet Rheumatology 3 (6), e419-e426, 2021 | 250 | 2021 |
| Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren’s syndrome. Data at enrollment in … JE Gottenberg, R Seror, C Miceli-Richard, J Benessiano, ... PloS one 8 (5), e59868, 2013 | 221 | 2013 |
| Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and … J Morel, R Audo, M Hahne, B Combe Journal of Biological Chemistry 280 (16), 15709-15718, 2005 | 221 | 2005 |
| A novel role for interleukin-18 in adhesion molecule induction through NFκB and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways JCM Morel, CC Park, JM Woods, AE Koch Journal of Biological Chemistry 276 (40), 37069-37075, 2001 | 220 | 2001 |
| Non–TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial JE Gottenberg, O Brocq, A Perdriger, S Lassoued, JM Berthelot, ... Jama 316 (11), 1172-1180, 2016 | 217 | 2016 |
| Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis C Rempenault, B Combe, T Barnetche, C Gaujoux-Viala, C Lukas, ... Annals of the rheumatic diseases 77 (1), 98-103, 2018 | 212 | 2018 |
| Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis CI Daïen, Y Duny, T Barnetche, JP Daurès, B Combe, J Morel Annals of the rheumatic diseases 71 (6), 862-868, 2012 | 196 | 2012 |
| Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers LK Mercer, J Askling, P Raaschou, WG Dixon, L Dreyer, ML Hetland, ... Annals of the rheumatic diseases 76 (2), 386-391, 2017 | 190 | 2017 |
| Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data … P Brito-Zerón, N Acar-Denizli, M Zeher, A Rasmussen, R Seror, ... Annals of the rheumatic diseases 76 (6), 1042-1050, 2017 | 187 | 2017 |
| How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project) P Brito-Zerón, N Acar-Denizli, WF Ng, M Zeher, A Rasmussen, T Mandl, ... Clinical and experimental rheumatology 36 (3), S102-S112, 2018 | 176 | 2018 |
